COVID-END: an international network to better co-ordinate and maximize the impact of the global evidence synthesis and guidance response to COVID-19

dc.creatorGrimshaw, Jeremy M.
dc.creatorTovey, David I.
dc.creatorLavis, John N.
dc.creatorCOVID-END
dc.date2021-01-15T13:00:27Z
dc.date2021-01-15T13:00:27Z
dc.date2020
dc.date.accessioned2023-09-26T23:58:23Z
dc.date.available2023-09-26T23:58:23Z
dc.identifierGRIMSHAW, Jeremy M. et al. COVID-END: an international network to better co-ordinate and maximize the impact of the global evidence synthesis and guidance response to COVID-19. Cochrane Database of Systematic Reviews, [s.l], v.12, p.4-8, 2020. Supl. 1.
dc.identifier1465-1858
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/45710
dc.identifier10.1002/14651858.CD202002
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8896117
dc.descriptionCOVID-END: Barreto, J. M. (Jorge Otávio Maia Barreto) – Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.; Al-Khateeb, S. – McMaster University. McMaster Health Forum. Hamilton, ON, Canada.; Akl, E. A. – American University of Beirut. Clinical Research Institute. Beirut, Lebanon.; Bai, Z. – Nanjing University of Science and Technology. Evidence-based Social Science and Health Research Center. Nanjing, JS, China.; Brandt, L. – MAGIC Evidence Ecosystem Foundation. Norway.; Brassey, J. – Trip Database. United Kingdom.; Boutron, I. – Université de Paris. Centre of Research in Epidemiology and Statistics. Paris, France.; Bullock, H.L. – McMaster University. McMaster Health Forum. RISE. Hamilton, ON, Canada.; Burke, N.N. – Cochrane Ireland. Galway, Ireland / Evidence Synthesis Ireland. Galway, Ireland; Chen, Y. –Lanzhou University. Evidence Based Medicine Centre. Lanzhou, GS , China. ; Ciurea, I. – McMaster University. McMaster Health Forum. Hamilton, ON, Canada.; Dieyi, N.U. – Memorial University of Newfoundland and Labrador. St. John's, N.L, Canada.; de Haan, S. – Cochrane. Heidelberglaan, Utrecht, Netherlands.; Dion, A. – Ottawa Hospital Research Institute. RISE. Ottawa, ON, Canada.; Dobbins, M. – McMaster University. National Collaborating Centre for Methods and Tools. Hamilton, ON, Canada.; El-Jardali, F. – American University of Beirut. Knowledge to Policy (K2P) Center. Beirut, Lebanon.; Elliott, J.H. – Cochrane Australia. Melbourne, VIC, Australia. ; Florez, I.D. – University of Antioquia. Medellín, ANT, Colombia.; Gough, D. – University College London. EPPI-Centre. London, United Kingdom.; Greenhalgh, T. – University of Oxford. Interdisciplinary Research In Health Sciences Research Group. Oxford, United Kingdom.; Henry, L. – Lucy Henry Consulting. Ottawa, ON, Canada.; Iorio, A. – McMaster University. Department of Health Research Methods, Evidence and Impact. Hamilton, ON, Canada.; Kamga, E.B. – Effective Basic Services (eBASE) Africa. Bamenda, Cameroon.; Kawala, B.A. – Makerere University. Africa Centre for Systematic Reviews and Knowledge Translation. Kampala, Uganda.; Kawooya, I. – Makerere University. College of Health Sciences. The Centre for Rapid Evidence Synthesis. Kampala, Uganda.; Kayongo, E. – Makerere University. College of Health Sciences. The Centre for Rapid Evidence Synthesis. Kampala, Uganda.; Kredo, T. – South African Medical Research Council, Cape Town, South Afric. Langer, L – University of Johannesburg. Africa Centre for Evidence. Johannesburg, South Africa.; Lewin, S. – Norwegian Institute of Public Health. Cochrane EPOC. Oslo, Norway / South African Medical Research Council, Cape Town, South Africa.; Lewis, S.Z. – EBQ Consulting, LLC. Austin, TX, United States.; Lockwood, C. – University of Adelaide. Faculty of Health and Medical Sciences. Joanna Briggs Institute. Adelaide, SA, Australia.; Lotfi,T. – American University of Beirut. Global Evidence Synthesis Initiative. Beirut, Lebanon / McMaster University. Health Research Methods, Evidence & Impact. Ottawa, ON, Canada.; Mavergames, C. – Germany Cochrane. Freiburg im Breisgau, Germany.; McCaul, M. – Stellenbosch University. Department of Global Health. Centre for Evidence Based Health Care. Stellenbosch, South Africa.; McQuillan, R. University of Edinburgh. Usher Institute. Edinburgh, United Kingdom.; Mijumbi-Deve, R. Makerere University. College of Health Sciences. The Centre for Rapid Evidence Synthesis. Kampala, Uganda.; Moat, K.A. – McMaster University. McMaster Health Forum. Hamilton, ON, Canada.; Munn, Z. – Guidelines International Network. Scotland / University of Adelaide. Faculty of Health and Medical Sciences. Joanna Briggs Institute. Adelaide, SA, Australia.; Nakibuuka, L.S. – Memorial University of Newfoundland and Labrador. St. John's, N.L, Canada.; Ndagire, R. – Makerere University. Africa Centre for Systematic Reviews and Knowledge Translation. Kampala, Uganda.; Nunan, D. – University of Oxford. Oxford Centre for Evidence-Based Medicine. Oxford. United Kingdom.; Obuku, E.A. – Makerere University. Africa Centre for Systematic Reviews and Knowledge Translation. Kampala, Uganda.; Ocan, M. – Makerere University. Africa Centre for Systematic Reviews and Knowledge Translation. Kampala, Uganda.; Okwen, P. M. – Effective Basic Services (eBASE) Africa. Bamenda, Cameroon.; Oliver, S. R. – University College London. EPPI-Centre. London, United Kingdom.; Ooi, C.P. – Universiti Putra Malaysia. Serdang, Malaysia.; Osheroff, J. A. – Initiative COVID-19 Guidance to Action Collaborative. AHRQ evidence-based Care Transformation Support. TMIT Consulting and Chair. Rockville, MD, United States.; Rada, G. – Epistemonikos Foundation, Santiago, Chile.; Reveiz, L. - Pan American Health Organization. Washington, D.C., United States.; Roy, D. – Institut National d’Excellence en Santé et en Services Sociaux. Quebec, ON, Canada.; Smith, M. – Cochrane consumer, Canada.; Snilstveit, B. – International Initiative for Impact Evaluation. London, United Kingdom.; Stewart, L.A. – University of York. Centre for Reviews and Dissemination. York, United Kingdom.; Stewart, R. – University of Johannesburg. Africa Centre for Evidence. Johannesburg, South Africa.; Sutherland, K. – Agency for Clinical Innovation. St Leonards, NSW, Australia.; Taske, N. L. – National Institute for Health and Care Excellence. London, United Kingdom.; Taylor, B.H. – Evidence Aid. Oxford, United Kingdom.; Thomas, J. – University College London. EPPI-Centre. London, United Kingdom.; Tricco, A.C. – Unity Health Toronto. Li Ka Shing Knowledge Institute of St. Michael’s Hospital. Toronto, ON, Canada.; Vandvik, P.O. – MAGIC Evidence Ecosystem Foundation. Norway.; Vist, G.E. – Norwegian Institute of Public Health. Oslo, Norway. ; Wangi, N.R. Makerere University. Africa Centre for Systematic Reviews and Knowledge Translation. Kampala, Uganda.; Welch, V. A. – Campbell Collaboration. Canada.; Wild, C. – European Network for Health Technology Assessment. Vienna, Austria.; Young, T. – Stellenbosch University. Department of Global Health. Centre for Evidence Based Health Care. Stellenbosch, South Africa.; Yu, X. – Lanzhou University. Evidence Based Medicine Centre. Lanzhou, GS, China.; Zhu, Y. – Lanzhou University. Evidence Based Medicine Centre. Lanzhou, GS, China.
dc.descriptionResearch, Evidence and Development Initiative (READ-It) e UK government.
dc.descriptionThe COVID-19 pandemic is one of the greatest health and societal challenges that the world has collectively faced in many decades. Policy, public health, clinical and individual decision makers are actively seeking evidence and evidence-based guidance (e.g. health technology assessments, clinical practice guidelines) on prevention, management and mitigation of the health, social and economic impacts of COVID-19. As a result, there has been a dramatic global increase in basic and applied health (and to a lesser extent social and economic) research. Given that individual studies are rarely sufficient to guide policy, clinical and individual decisions, and the evidence base is rapidly evolving, decision makers need highquality, context-relevant evidence syntheses and trustworthy guidance more than ever. It was heartening then, to see a dramatic increase in evidence synthesis, guidance and associated decision support activities globally to meet the needs of the pandemic during the first half of 2020.Many of the eventual partners in COVID-END were involved in some type of evidence synthesis, guidance and support activities when COVID-19 struck. These partners rapidly pivoted to focus their work on COVID-19. We (JMG, JNL) observed that during the initial stages of the pandemic, the evidence synthesis response largely focused on rapid reviews, which were rapidly out of date despite the ongoing relevance of the review question and were of variable quality, and that guidance development largely focused on expert opinion. There was also huge duplication of effort globally, creating a major noise to signal problem. We decided to convene a series of exploratory meetings in early April of the key global evidence synthesis, guidance and decision support organizations to see whether other groups shared our concerns.We also explored whether there was an appetite to work together to promote collaboration, improve the efficiency of evidence synthesis and guidance production and decision support activities, and reduce inappropriate duplication of effort in order to maximize the impact of the global evidence response to COVID-19. Following these meetings, we established COVID-END: the COVID-19 Evidence Network to support Decision-making (covid-end.org/), as a time-limited network of global evidence synthesis, guidance and decision support organizations that aims better to co-ordinate their collective evidence response to the pandemic.
dc.formatapplication/pdf
dc.languageeng
dc.publisherJohn Wiley & Sons
dc.rightsopen access
dc.subjectCoronavirus Infections
dc.subjectPandemics
dc.subjectEvidence-Based Medicine
dc.subjectInformation Services
dc.subjectGlobal Health
dc.subjectCOVID-19
dc.subjectPandemic
dc.subjectEvidence-informed policy
dc.subjectScience and technology information networks
dc.subjectRedes de Informação de Ciência e Tecnologia
dc.subjectPolítica Informada por Evidências
dc.subjectCooperação Internacional
dc.subjectInfecções por Coronavirus
dc.subjectPandemias
dc.subjectSaúde Global
dc.titleCOVID-END: an international network to better co-ordinate and maximize the impact of the global evidence synthesis and guidance response to COVID-19
dc.typeArticle


Este ítem pertenece a la siguiente institución